Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
taxon 5671Also known as: Leishmania (Leishmania) infantum, Leishmania donovani infantum
No local or indigenous names recorded yet.
Not yet assessed
Occurrence records: Recorded mostly outside Africa. 123 of 1,567 GBIF records (8%) are from Africa (checked 10/9/2026). A hint from GBIF and the genomes on this Hub, not an assessment: GBIF includes zoo and travel records.
Species that share this one's nearest groups in NCBI Taxonomy. This is how they're classified, not a phylogeny. See it in the species tree.
The assembly file for Leishmania infantum hasn't finished reaching the Hub yet — check back shortly.
Origin: hub
0 downloads
First synced: 8/26/2026 · Last updated: 8/26/2026
Source: NCBI OR818042.1 · View at source ↗
Collection: Sri Lanka
Released: 2024-01-29
publiccc0AFDSI-SEQ-625 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: LK · PIC: unknown · MAT: unknown
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 8/26/2026 · Last updated: 8/26/2026
Source: NCBI GCA_037178145.1 · View at source ↗
Collection: Tunisia: Monastir
Sequencing: Oxford Nanopore GridION · GS De Novo Assembler v. 2023 · 4860x coverage
Released: 2024-03-15 · Submitted by: Nano1Health
publiccc0AFDSI-SEQ-221 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: TN · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 0.03 Gb · scaffold N50 631,274 · View at source ↗
Publicly accessible — no request needed.
protein 2228 — 560 aa
protein 2229 — 365 aa
protein 2230 — 375 aa
protein 2231 — 671 aa
JBP1 — 814 aa
FEN1 — 395 aa
protein 2234 — 895 aa
protein 2235 — 834 aa
protein 2236 — 409 aa
protein 2237 — 412 aa
AlphaFold DB proteome: UP000008153 ↗
PRIDE — project-level reference (metadata only; no per-protein identifications are available via PRIDE's public API)
Affinity purification-mass spectrometry to identify proteins interacting with Leishmania LINF_180011100 (PXD062031) ↗AFDSI-PROJREF-207
Extracellular vesicles proteomic profile in anti-TNF immunosuppressed mice: insights into protein dysregulation during Leishmania infantum infection (PXD060935) ↗AFDSI-PROJREF-208
Proteomic analysis of Plasma-derived Extracellular Vesicles reveals different biomarkers for monitoring visceral leishmaniasis progression (PXD060604) ↗AFDSI-PROJREF-209
The related EIF4G3 and EIF4G4 initiation factors from Leishmania: dissimilar modes of action during translation revealed by a comparative proteomic approach (PXD058985) ↗AFDSI-PROJREF-210
Quantitative proteomics of infected macrophages reveals novel Leishmania virulence factors (PXD058427) ↗AFDSI-PROJREF-211
Mass spectrometry analysis of the Skp1 and Cullin1 interactome in Leishmania infantum (PXD051961) ↗AFDSI-PROJREF-212
Proteomic characterization of extracellular vesicles recovered from peripheral blood from a patient with active leishmaniasis in the context of HIV co-infection (PXD049001) ↗AFDSI-PROJREF-213
T. brucei whole cell proteome changes upon exposure to the experimental phthalimide-based trypanocidal drug PHT-39 (PXD043204) ↗AFDSI-PROJREF-214
ChEMBL rows are compounds active against a protein target from this organism — not confirmed as compounds the species itself produces, unlike ANPDB's.
ChEMBL: CHEMBL164580 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-385
ChEMBL: CHEMBL166314 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-386
ChEMBL: CHEMBL165097 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-387
ChEMBL: CHEMBL166092 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 6750.0 nMAFDSI-METABOLOMICS-388
ChEMBL: CHEMBL349670 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-389
ChEMBL: CHEMBL166069 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-390
ChEMBL: CHEMBL350978 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 23300.0 nMAFDSI-METABOLOMICS-391
ChEMBL: CHEMBL350506 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-392
ChEMBL: CHEMBL166182 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 3700.0 nM
KEGG: KEGG genome-based metabolic profile (lif) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presenceAFDSI-METABPROF-112
pLDDT confidence: unknown
Auto-synced from PDBe 6az1 · View at source ↗
publiccc_byAFDSI-STRUCT-5289-V2pLDDT confidence: 73.1
Auto-synced from AlphaFold DB AF-A4HVV6-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-13443-V2pLDDT confidence: 84.1
Auto-synced from AlphaFold DB AF-A4I738-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-13429-V2pLDDT confidence: 89.8
Auto-synced from AlphaFold DB AF-A4HUG1-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-13439-V2pLDDT confidence: 90.2
Auto-synced from AlphaFold DB AF-A4I438-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-13427-V2BioImage Archive: Micro-CT visualization of a promastigote secretory gel (PSG) and parasite plug in the digestive tract of the sand fly Lutzomyia longipalpis infected with Leishmania mexicana (View on source archive ↗)AFDSI-CELL-471
BioImage Archive: TrypTag: Genome-wide subcellular protein localisation in Trypanosoma brucei. (View on source archive ↗)AFDSI-CELL-472
BioImage Archive: LeishTag: Leishmania protein subcellular localisation through the life cycle (View on source archive ↗)AFDSI-CELL-6906
124 real GBIF-recorded occurrences across Africa — see this species on GBIF ↗.
This reflects real occurrence records submitted to GBIF, not a comprehensive range map — sampling effort varies significantly by country and region, so an absence here doesn't mean the species isn't present.
A node's own derived bioinformatics-analysis output (e.g. an SSR/microsatellite discovery archive) run against this species' own genome data — see the Derived Analysis page for the full catalog.
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-221
File: GCA_037178145.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-17172ChEMBL: CHEMBL351276 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 100000.0 nMAFDSI-METABOLOMICS-394
ChEMBL: CHEMBL242165 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 70.0 %AFDSI-METABOLOMICS-395
ChEMBL: CHEMBL242163 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-396
ChEMBL: CHEMBL4097340 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 75000.0 nMAFDSI-METABOLOMICS-397
ChEMBL: CHEMBL4070159 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 14400.0 nMAFDSI-METABOLOMICS-398
ChEMBL: CHEMBL4105040 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 9900.0 nMAFDSI-METABOLOMICS-399
ChEMBL: CHEMBL4080816 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 20800.0 nMAFDSI-METABOLOMICS-400
ChEMBL: CHEMBL4076896 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 13500.0 nMAFDSI-METABOLOMICS-401
ChEMBL: CHEMBL4129161 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-402
ChEMBL: CHEMBL4290914 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-403
ChEMBL: CHEMBL4281347 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-404
ChEMBL: CHEMBL4276822 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-405
ChEMBL: CHEMBL4128885 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition %AFDSI-METABOLOMICS-406
ChEMBL: CHEMBL3629567 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Kd 8.4 nMAFDSI-METABOLOMICS-407
ChEMBL: CHEMBL1236677 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Kd 2.0 nMAFDSI-METABOLOMICS-408
ChEMBL: CHEMBL3503055 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect -2.778 %AFDSI-METABOLOMICS-409
ChEMBL: CHEMBL3442215 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect -1.389 %AFDSI-METABOLOMICS-410
ChEMBL: CHEMBL3442218 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect -4.167 %AFDSI-METABOLOMICS-411
ChEMBL: CHEMBL3442273 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect 8.333 %AFDSI-METABOLOMICS-412
ChEMBL: CHEMBL3499903 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect 1.389 %AFDSI-METABOLOMICS-413
ChEMBL: CHEMBL3503095 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect 9.722 %AFDSI-METABOLOMICS-414
ChEMBL: CHEMBL3503077 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect -1.389 %AFDSI-METABOLOMICS-415
ChEMBL: CHEMBL3503057 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect 11.11 %AFDSI-METABOLOMICS-416
ChEMBL: CHEMBL3499880 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect 16.67 %AFDSI-METABOLOMICS-417
ChEMBL: CHEMBL3504617 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Percent Effect 5.556 %AFDSI-METABOLOMICS-418
ChEMBL: SURFACTIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 35200.0 nMAFDSI-METABOLOMICS-615
ChEMBL: BNIPDANON (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 5700.0 nMAFDSI-METABOLOMICS-616
ChEMBL: BNIPDAOCT (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 9200.0 nMAFDSI-METABOLOMICS-617
ChEMBL: SIRTINOL (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 193800.0 nMAFDSI-METABOLOMICS-618
ChEMBL: NIACINAMIDE (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 39400.0 nMAFDSI-METABOLOMICS-619
ChEMBL: CHEMBL4216559 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 5700.0 nMAFDSI-METABOLOMICS-620
ChEMBL: SURAMIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 7000.0 nMAFDSI-METABOLOMICS-621
ChEMBL: CHEMBL4211052 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 5700.0 nMAFDSI-METABOLOMICS-622